ORIC Pharmaceuticals Ownership | Who Owns ORIC Pharmaceuticals?
ORIC Pharmaceuticals Ownership Summary
ORIC Pharmaceuticals is owned by 109.80% institutional investors, 1.69% insiders. Nextech invest is the largest institutional shareholder, holding 7.49% of ORIC shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.86% of its assets in ORIC Pharmaceuticals shares.
ORIC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ORIC Pharmaceuticals | 109.80% | 1.69% | -11.49% |
| Sector | Healthcare Stocks | 129.40% | 12.08% | -41.48% |
| Industry | Biotech Stocks | 181.71% | 11.69% | -93.40% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nextech invest | 5.29M | 7.49% | $42.66M |
| Blackrock | 4.83M | 7.17% | $34.15M |
| Nextech invest | 7.16M | 6.79% | $77.57M |
| Blackrock funding, inc. /de | 6.98M | 6.46% | $94.01M |
| Ecor1 capital | 6.73M | 6.38% | $72.87M |
| Price t rowe associates inc /md/ | 6.62M | 6.27% | $71.67M |
| Viking global investors lp | 5.13M | 4.86% | $55.52M |
| Vanguard group | 4.54M | 4.59% | $37.15M |
| Sr one capital management, lp | 4.62M | 4.38% | $49.98M |
| Vr adviser | 4.32M | 4.10% | $46.78M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Column group | 3.54M | 43.53% | $38.35M |
| Invus financial advisors | 1.01M | 7.98% | $7.12M |
| Nextech invest | 5.29M | 6.92% | $42.66M |
| Sr one capital management, lp | 4.62M | 4.81% | $49.98M |
| Nextbio capital management lp | 684.48K | 3.93% | $9.22M |
| Nextech invest | 7.16M | 3.68% | $77.57M |
| Ecor1 capital | 6.73M | 3.54% | $72.87M |
| Pfizer | 372.90K | 2.99% | $4.91M |
| Nea management company | 4.12M | 2.81% | $44.60M |
| Superstring capital management lp | 406.08K | 2.78% | $4.40M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.83M | 0.00% | 1.65M |
| D. e. shaw | 1.58M | 0.01% | 1.54M |
| Price t rowe associates inc /md/ | 6.62M | 0.01% | 1.23M |
| Algert global | 1.22M | 0.16% | 1.08M |
| Goldman sachs group | 2.45M | 0.00% | 976.08K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | - | - | -2.92M |
| Commodore capital lp | - | - | -2.00M |
| Paradigm biocapital advisors lp | - | - | -1.70M |
| Avidity partners management lp | - | - | -1.27M |
| Frazier life sciences management | - | - | -1.07M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma investments, lp | 603.66K | 0.00% | 603.66K | $6.54M |
| Zweig-dimenna associates | 268.79K | 0.28% | 268.79K | $3.62M |
| Driehaus capital management | 148.78K | 0.01% | 148.78K | $1.79M |
| Walleye capital | 63.08K | 0.00% | 63.08K | $849.67K |
| Caption management | 48.13K | 0.00% | 48.13K | $521.25K |
Sold Out
| Holder | Change |
|---|---|
| Capital performance advisors llp | -1.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Stone house investment management | -18.00 |
| Coldstream capital management | -45.00 |
| Covestor | -48.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 212 | 12.17% | 118,593,940 | -4.54% | 109 | 0.79% | 120 | 5.26% | 55 | 27.91% |
| Jun 30, 2026 | 187 | 1.08% | 124,132,386 | 4.00% | 117 | 0.92% | 112 | 14.29% | 43 | -31.75% |
| Mar 31, 2026 | 181 | 9.04% | 114,725,898 | -4.12% | 130 | 0.89% | 94 | -7.84% | 64 | 77.78% |
| Dec 31, 2025 | 56 | -63.87% | 20,254,766 | -80.98% | 20 | 0.11% | 33 | -63.74% | 16 | -52.94% |
| Sep 30, 2025 | 52 | -62.04% | 16,331,312 | -82.02% | 20 | 0.15% | 33 | -54.17% | 13 | -74.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.96M | 2.86% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.92M | 2.82% | 180.40K |
| Vanguard Morn Total Stk Mkt Idx Investor | 2.92M | 2.82% | 180.40K |
| Vanguard US Total Market Shares ETF | 1.88M | 2.65% | - |
| State Street® SPDR® S&P® Biotech ETF | 2.59M | 2.50% | 67.89K |
| iShares Russell 2000 ETF | 1.88M | 1.82% | - |
| Fidelity Growth Compy Commingled Pl O | 1.28M | 1.81% | - |
| ACAP Strategic A | 1.85M | 1.79% | -375.60K |
| Fidelity Growth Compy Commingled Pl S | 1.32M | 1.28% | - |
| T. Rowe Price Integrated US SmCapGrEq | 1.26M | 1.22% | 311.10K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 20, 2026 | Piscitelli Dominic | Chief Financial Officer | Sell | $189.39K |
| Oct 01, 2026 | Heyman Richard A. | - | Sell | $45.20K |
| Oct 01, 2026 | Heyman Richard A. | - | Sell | $41.33K |
| Sep 28, 2026 | Piscitelli Dominic | Chief Financial Officer | Sell | $181.26K |
| Sep 24, 2026 | Piscitelli Dominic | Chief Financial Officer | Sell | $1.35K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 3 |
| 2026 Q3 | - | 7 |
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 3 |
ORIC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools